Arthur Booker+FollowThe Weight Loss Pill With a Tongue-Twister NameEli Lilly just dropped big news: their new daily weight loss pill works wonders, but good luck saying its name—'orforglipron.' (Try that with your morning coffee!) The real buzz? Unlike Ozempic shots, this one’s a simple pill you can take anytime, no food rules. Investors are hyped, but Novo Nordisk (the Ozempic folks) aren’t thrilled. If you hate needles, keep an eye out for this hard-to-pronounce game-changer! #weightloss #healthnews #pharma #investing #lifetips #Business360Share
William Vasquez+FollowHIV Drug Showdown: New Regimens vs. OldBig news for HIV treatment in China: Newer INSTI-based regimens (like Biktarvy) are just as effective and safe as the old standard, but they’re better for drug resistance and sticking to your meds. The catch? They’re cost-effective for patients but not for the healthcare system (unless prices drop). If you’re weighing options or watching policy shifts, this could shake up first-line HIV care soon! #HIVTreatment #HealthNews #Pharma #ChinaHealth #CostEffectiveness #Health202Share
